In this study, we confirmed that ITGB3BP could lead to a poor prognosis of glioma, but the regulatory effect of ITGB3BP overexpression on the cell signalling pathway needs to be further elucidated. The gene discussed is ITGB3BP; the disease is central nervous system cancer.